Research at the Hebrew University of Jerusalem may have “groundbreaking implications” for eradicating the HIV virus, according to the school’s research team, the university announced. The treatment, which destroys HIV-infected human cells in laboratory cultures, targets only infected cells without damaging adjacent healthy cells.
“The findings are an exciting development in the quest to eradicate this devastating pandemic,” said Dr. Abraham Loyter of Hebrew University’s Silberman Institute of Life Sciences, whose findings were reported in the AIDS Research and Therapy journal. The therapy developed by his research team has been patented through Yissum, the school’s technology transfer company.
The New York Jewish Week brings you the stories behind the headlines, keeping you connected to Jewish life in New York. Help sustain the reporting you trust by donating today.
